A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection

A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection

PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.

Bibliographic Details
Main Authors: Fawziah Marra, Carlo A Marra, H Grant Stiver
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2003/453183
id doaj-9f09c2b865bc4c248fc3c9c34fb6d0e8
record_format Article
spelling doaj-9f09c2b865bc4c248fc3c9c34fb6d0e82021-07-02T02:01:43ZengHindawi LimitedCanadian Respiratory Journal1198-22412003-01-0110738138810.1155/2003/453183A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus InfectionFawziah Marra0Carlo A Marra1H Grant Stiver2Faculty of Pharmaceutical Sciences, University of British Columbia, and British Columbia Centre for Disease Control, CanadaFaculty of Pharmaceutical Sciences, University of British Columbia, and Centre for Health Evaluation and Outcomes Sciences, St Paul’s Hospital, Department of Health Care and Epidemiology, Faculty of Medicine, CanadaFaculty of Medicine, University of British Columbia, and Division of Infectious Diseases, Department of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, CanadaPURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.http://dx.doi.org/10.1155/2003/453183
collection DOAJ
language English
format Article
sources DOAJ
author Fawziah Marra
Carlo A Marra
H Grant Stiver
spellingShingle Fawziah Marra
Carlo A Marra
H Grant Stiver
A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
Canadian Respiratory Journal
author_facet Fawziah Marra
Carlo A Marra
H Grant Stiver
author_sort Fawziah Marra
title A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
title_short A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
title_full A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
title_fullStr A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
title_full_unstemmed A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
title_sort case for rimantadine to be marketed in canada for prophylaxis of influenza a virus infection
publisher Hindawi Limited
series Canadian Respiratory Journal
issn 1198-2241
publishDate 2003-01-01
description PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.
url http://dx.doi.org/10.1155/2003/453183
work_keys_str_mv AT fawziahmarra acaseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection
AT carloamarra acaseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection
AT hgrantstiver acaseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection
AT fawziahmarra caseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection
AT carloamarra caseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection
AT hgrantstiver caseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection
_version_ 1721343966999216128

Similar Items